
EVOLENT HEALTH INC - A
EVHNYSETrading Snapshot
- Day Range
- $4.05 โ $4.16
- 52-Week Range
- $2.10 โ $10.08
- Volume
- $5.66B
- Avg Volume
- $5.83B
- Shares Outstanding
- 112.5M
- Next Earnings
- Sep 19, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.88B
- Last Q Revenue
- $653M
- P/E Ratio
- โ
- P/S Ratio
- 0.2x
- EPS (TTM)
- $-4.52
- Dividend Yield
- โ
Why Investors Own EVH
- โHigh-growth profile โ revenue up +0.4% YoY with expanding US Equity exposure.
- โHealthy economics โ 48% gross margin and 7% free-cash-flow margin.
- โNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About EVOLENT HEALTH INC - A
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
Otter Score Breakdown
โAnalyst Ratings
โLatest News & Updates
Citigroup Upgrades Evolent Health (EVH)
Citigroup Upgrades Evolent Health to Buy, Lowers Price Target to $6
Citigroup analyst Daniel Grosslight upgrades Evolent Health (NYSE:EVH) from Neutral to Buy and lowers the price target from $6.75 to $6.
Evolent Health, Inc. 2026 Q2 - Results - Earnings Call Presentation

12 Health Care Stocks Moving In Monday's After-Market Session
Gainers P3 Health Partners (NASDAQ:PIII) shares increased by 24.1% to $15.92 during Monday's after-market session. The market value of their outstanding shares is at $38.5 million. As per the press release, Q2
Canaccord Genuity Maintains Buy on Evolent Health, Lowers Price Target to $6
Canaccord Genuity analyst Richard Close maintains Evolent Health (NYSE:EVH) with a Buy and lowers the price target from $7 to $6.

Evolent Health Q2 Earnings Call Highlights
Evolent Health (NYSE:EVH) reported second-quarter revenue of $653 million, up 31% from the first quarter, and adjusted EBITDA of $28 million, up 27% sequentially, as the company benefited from the May launch of its Highmark partnership and continued growth in its Performance Suite business. Chief E